Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Blue Trust Inc.

Blue Trust Inc. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 27.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,747 shares of the medical equipment provider's stock after acquiring an additional 1,014 shares during the period. Blue Trust Inc.'s holdings in Intuitive Surgical were worth $2,332,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Bennett Selby Investments LP boosted its position in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after acquiring an additional 17 shares during the last quarter. LVW Advisors LLC grew its holdings in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its holdings in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after acquiring an additional 19 shares in the last quarter. Hazlett Burt & Watson Inc. increased its holdings in Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock valued at $177,000 after buying an additional 20 shares during the last quarter. Finally, Mitchell Mcleod Pugh & Williams Inc. raised its stake in Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider's stock valued at $247,000 after buying an additional 20 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Royal Bank of Canada lifted their target price on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday. Barclays boosted their price target on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday. Truist Financial lifted their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a report on Friday. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. Finally, Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $613.10.

Insider Buying and Selling

In other news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company's stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 42,265 shares of company stock valued at $21,964,281. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $0.66 during trading on Tuesday, reaching $574.14. 2,331,432 shares of the company's stock were exchanged, compared to its average volume of 2,043,553. The company's 50-day moving average is $548.00 and its two-hundred day moving average is $506.12. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market cap of $204.50 billion, a price-to-earnings ratio of 92.31, a PEG ratio of 5.19 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.